(Q77576375)

English

Novel compounds, 1,3-selenazine derivatives, as antibacterial agents against Escherichia coli and Staphylococcus aureus

scientific article published on 01 August 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

title

Novel compounds, 1,3-selenazine derivatives, as antibacterial agents against Escherichia coli and Staphylococcus aureus (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

main subject

Staphylococcus aureus

1 reference

1 reference

Koketsu M

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

Ishihara H

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

Hatsu M

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

publication date

1 August 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

published in

Research Communications in Molecular Pathology and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

volume

101

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

page(s)

179-186

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 December 2019

Identifiers

PubMed publication ID

9821214

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9821214

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9821214%20AND%20SRC:MED&resulttype=core&format=json

(Q77576375)

Novel compounds, 1,3-selenazine derivatives, as antibacterial agents against Escherichia coli and Staphylococcus aureus

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)